Litha Healthcare Group Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Litha Healthcare Group Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014386
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. The company operates through its three divisions such as pharmaceuticals, medical devices and biotechnology. Its pharma division offers generic, originator and complementary medicines in the therapeutic areas of oncology, gastroenterology, neurology, urology and dermatology, among others. Litha Healthcare provides medical devices, consumables and equipment serving the therapeutic areas of ophthalmology, orthopaedics and sports medicine, surgery and others. Litha Healthcare’s biotechnology division manufactures and research and development of human vaccines. The company also has international partnerships with several pharmaceutical and medical companies and institutes. Litha Healthcare is headquartered in Midrand, South Africa.

Litha Healthcare Group Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Litha Healthcare Group Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 11
Partnerships 12
Litha Pharma Partners with Gland Pharma 12
Litha Pharma Partners with NTC 13
Litha Healthcare Enters Into Co-Development Agreement With Micro Labs 14
Litha Pharma Partners with Natco Pharma 15
Licensing Agreements 16
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 16
Asset Transactions 17
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 17
Acquisition 18
Acino Pharma Acquires Litha Healthcare from Endo International 18
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 20
Litha Healthcare Acquires OTC Pharma South Africa 21
Litha Healthcare Acquires Goldex Healthcare For US$4 Million 22
Litha Healthcare Group Ltd – Key Competitors 23
Litha Healthcare Group Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Litha Healthcare Group Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Litha Healthcare Group Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Litha Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 11
Litha Pharma Partners with Gland Pharma 12
Litha Pharma Partners with NTC 13
Litha Healthcare Enters Into Co-Development Agreement With Micro Labs 14
Litha Pharma Partners with Natco Pharma 15
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 16
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 17
Acino Pharma Acquires Litha Healthcare from Endo International 18
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 20
Litha Healthcare Acquires OTC Pharma South Africa 21
Litha Healthcare Acquires Goldex Healthcare For US$4 Million 22
Litha Healthcare Group Ltd, Key Competitors 23
Litha Healthcare Group Ltd, Subsidiaries 24

★海外企業調査レポート[Litha Healthcare Group Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務情報
    Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Duke Energy Carolinas LLC:企業の発電所・SWOT分析2018
    Duke Energy Carolinas LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Dow Inc (DOW):企業の財務・戦略的SWOT分析
    Dow Inc (DOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Cellectricon AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectricon AB (Cellectricon) is an advanced cell-based discovery service provider. The company offers automated cell-based screening technologies for drug discovery and basic research. It provides Cellaxess, a platform that allows the researchers to address critical bottlenecks in the drug …
  • National Bank of Greece SA:企業のM&A・事業提携・投資動向
    National Bank of Greece SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Bank of Greece SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Amgen, Inc.:企業の戦略・SWOT・財務情報
    Amgen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amgen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Gene Techno Science Co Ltd (4584):製薬・医療:M&Aディール及び事業提携情報
    Summary Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for intractable diseases, cancer, and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-004, for oncology; GND-001 for immunological disease …
  • Nuformix Plc (NFX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuformix Plc (Nuformix), formerly Levrett plc, is a pharmaceutical company which develops cocrystal forms of approved small molecules. Its product candidates which are in clinical and pre-clinical development include NXP001, NXP002, and NXP003 for the treatment of oncology supportive care an …
  • Coal India Ltd:企業のM&A・事業提携・投資動向
    Coal India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coal India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • PanAtlantic Exploration Co:企業の戦略的SWOT分析
    PanAtlantic Exploration Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • HeartSciences:医療機器:M&Aディール及び事業提携情報
    Summary HeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presen …
  • Tetra Tech Inc:企業の戦略・SWOT・財務分析
    Tetra Tech Inc - Strategy, SWOT and Corporate Finance Report Summary Tetra Tech Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mettler-Toledo International Inc:企業の戦略・SWOT・財務情報
    Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report Summary Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Origin Energy Limited:企業の戦略・SWOT・財務分析
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ANGLE Plc (AGL):医療機器:M&Aディール及び事業提携情報
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • Vertex Pharmaceuticals Inc (VRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that carries out the discovery, development and commercialization of novel drugs for the treatment of serious and life-threatening diseases. The company offers Orkambi (ivacaftor/lumacaftor) and Kalydeco (ivacaftor) for the treat …
  • Enterprise Ireland:医療機器:M&Aディール及び事業提携情報
    Summary Enterprise Ireland (EI) is an economic development organization that offers enterprise development programs. The organization’s activities include funding supports, export assistance, supports to develop competitiveness, incentives to stimulate in-company research and development, assistance …
  • Flex Ltd (FLEX):電力:M&Aディール及び事業提携情報
    Summary Flex Ltd (Flex) provides design, engineering, manufacturing, and supply chain services to electronics original equipment manufacturers. The company, through its Sketch-to-Scale concept, provides concept design, prototype creation, intellectual property protection, new product introduction, a …
  • Kresta Holdings Limited (KRS):企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Oil Refineries Ltd (ORL):企業の財務・戦略的SWOT分析
    Oil Refineries Ltd (ORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆